Shenzhen Mindray Bio-Medical Electronics News

Golden Research丨CICC Securities: Maintains a 'buy' rating on Shenzhen Mindray Bio-Medical Electronics, bullish on the company's future development.

Gelonghui FinanceNov 12 13:49

Mindray Healthcare (300760): Performance is in line with expectations, overseas business growth is impressive

Changjiang SecuritiesNov 11 20:52

Mindray Healthcare (300760) 2024 Q3 Report Review: International Market Continues to Gain Strength, IVD Business Leads Growth

Huachuang SecuritiesNov 5 18:22

Research Reports Spotlight | Zheshang maintains a "buy" rating on Shenzhen Mindray Bio-Medical Electronics, expecting to sustain a relatively stable growth trend in 2025-2026.

Gelonghui FinanceNov 4 15:17

Mindray Healthcare (300760): Domestic income fluctuations do not change long-term investment value

zheshang securitiesNov 4 13:02

Mindray Healthcare (300760): Overseas IVD is growing faster under short-term pressure in 24Q3

Southwest SecuritiesNov 4 00:00

Mindray Healthcare (300760): Domestic growth under pressure in 2024Q3, continued high overseas growth

huaan SecuritiesNov 2 00:00

Mindray Healthcare (300760): Domestic growth is under pressure, overseas growth continues to be high

gtjaNov 1 18:37

Mindray Healthcare (300760): Short-term performance is under pressure and looks forward to recovery next year

soochow securitiesNov 1 00:00

Mindray Healthcare (300760) 2024 Third Quarterly Report Review: Short-term performance is under pressure, optimistic about subsequent recovery

Minsheng SecuritiesOct 31 18:42

MINDRAY(300760):EXPECT DOMESTIC BUSINESS TO REBOUND FROM 2025

Oct 31 11:47

Deep* Company* Mindray Healthcare (300760): Domestic market revenue is under pressure, international market revenue continues to grow steadily

boc internationalOct 31 00:00

Mindray Healthcare (300760) 2024 Third Quarterly Report Review: Rapid Overseas Business Growth Continues to Monitor Equipment Updates Implementation Progress

orient securitiesOct 31 00:00

Mindray Healthcare (300760): External policies affect short-term performance, optimistic about the implementation of domestic equipment upgrades and continued breakthroughs in overseas markets

zhongtai securitiesOct 30 00:00

Mindray Healthcare (300760): Strong international business growth, maintaining high R&D investment

Sinolink securitiesOct 30 00:00

Nomura Adjusts Shenzhen Mindray Bio-Medical Electronics' Price Target to 418.21 Yuan From 425.97 Yuan, Keeps at Buy

MT NewswiresOct 16 15:10

Mindray Healthcare (300760): High-quality performance growth, deepening digital intelligence

CITIC SecuritiesSep 16 00:00

Mindray Healthcare (300760): Steady growth in performance, outstanding IVD business performance

華創證券Sep 14 00:00

Research Reports Uncover Gold | Guosen Securities: Maintains shenzhen mindray bio-medical electronics' "Outperform" rating, outstanding performance in the in vitro diagnostics business.

Gelonghui FinanceSep 9 15:20

Mindray Healthcare (300760): Net profit to mother increased 14% in the second quarter of a single quarter, and the in vitro diagnosis business performed well

Sep 9 12:51